专利检索 ap:("The Government of the United States of America as represented by the Secretary of the Dep. of H.H.S." OR "Merck Sharp & Dohme Corp.") AND inv:"Rachel Caspi" 第 1 页

1.

发明申请
USE OF IL-23 AND IL-17 ANTAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE 审中-公开
标题翻译：使用IL-23和IL-17拮抗剂治疗自身免疫性眼炎性炎症

公开(公告)号：US20130323251A1

公开(公告)日：2013-12-05

申请号：US13960441

申请日：2013-08-06

申请人： The Government of the United States of America as represented by the Secretary of the Dep. of H.H.S. , Merck Sharp & Dohme Corp.

发明人： Daniel J. Cua , Robert A. Kastelein , Van T. Tsai , Rachel Caspi , Phyllis Silver , Dror Luger

IPC分类号： A61K39/395

CPC分类号： C07K16/244 , A61K39/3955 , A61K2039/505 , C07K2317/76

摘要： Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.

摘要翻译： 公开了用于治疗自身免疫性眼部炎性疾病的新方法和药物产品，其包括施用拮抗IL-17和IL-23活性中的一种或两种的药剂。

2.

发明申请
USE OF IL-23 AND IL-17 ANTIAGONISTS TO TREAT AUTOIMMUNE OCULAR INFLAMMATORY DISEASE 审中-公开
标题翻译：使用IL-23和IL-17抗体治疗自身免疫性眼炎性炎症

公开(公告)号：US20140248279A1

公开(公告)日：2014-09-04

申请号：US14274905

申请日：2014-05-12

申请人： Merck Sharp & Dohme Corp. , The Government of the United States of America as represented by the Secretary of the Department of

发明人： Daniel J. Cua , Robert A. Kastelein , Van T. Tsai , Rachel Caspi , Phyllis Silver , Dror Luger

IPC分类号： C07K16/24

CPC分类号： C07K16/244 , A61K39/3955 , A61K2039/505 , C07K2317/76

摘要： Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.

摘要翻译： 公开了用于治疗自身免疫性眼部炎性疾病的新方法和药物产品，其包括施用拮抗IL-17和IL-23活性中的一种或两种的药剂。